The Challenge of microRNA as a Biomarker of Epilepsy
- PMID: 28676013
- PMCID: PMC5771381
- DOI: 10.2174/1570159X15666170703102410
The Challenge of microRNA as a Biomarker of Epilepsy
Abstract
Background: Epilepsy is one of chronic severe neurological disorders possess to recurring seizures. And now anti-epileptic drugs are only effective in less than one third of epilepsy patients, and biomarkers predicting are not available when the specific antiepileptic drugs treated. Advanced studies have showed that miRNA may be a key in the pathogenesis of epilepsy beginning in the early 2000 years. Several target genes and pathways of miRNA which related to the therapeutic methods to epilepsy.
Method: We searched PubMed from Jan 1,2000 to Jan 1, 2017, using the terms "epilepsy AND microRNA AND biomarker" and "seizure AND microRNA AND biomarker". We selected articles that featured novel miRNAs in vivo epilepsy models and patients. We then selected the most relevant articles based on a subjective appraisal of their quality and mechanistic insight that could be relevant to epilepsy.
Results: Decrease the expression of has-miR134 could be a potential non-invasive biomarker to use in diagnosis for the epilepsy patients for using hsa-miR-134 also be identified to distinguish patients with and without epilepsy. miR-181a show significant downregulation in the acute stage, but up regulation in the chronic stage and in the latent stage there is no changing and how about this phenomenon appearance in different stage still should be discussed in the future. Besides that, miR- 146a can down-regulated in the patients using genome-wide for serum in circulating miRNAs.miR- 124, miR-199a, and miR-128 etc. could be a candidate for the biomarker in future. miR-15a-5p and -194-5p down-regulated in epilepsy patients, in the future, it may be used as a novel biomarker for improve diagnosis.
Conclusion: These observations give a chance that new development for diagnosis and treatment of epilepsy patients. Advanced technique and miRNA combination may product more effective roles in epilepsy and other disease. These reports will be available to solve the application of miRNAs as biomarkers and novel therapy approaches for epilepsy. In summary, researcher who focus on miRNAs should be understanding of the causes, treatment, and diagnosis of epilepsy. exploration of any of these effects on the efficacy of these drugs is worthwhile.
Keywords: Status epilepticus; diagnosis; epilepsy; epileptogenesis; microRNA; temporal lobe epilepsy; therapy.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.
Similar articles
-
Genome-wide microRNA profiling of plasma from three different animal models identifies biomarkers of temporal lobe epilepsy.Neurobiol Dis. 2020 Oct;144:105048. doi: 10.1016/j.nbd.2020.105048. Epub 2020 Aug 13. Neurobiol Dis. 2020. PMID: 32800995
-
Targeting of microRNA-199a-5p protects against pilocarpine-induced status epilepticus and seizure damage via SIRT1-p53 cascade.Epilepsia. 2016 May;57(5):706-16. doi: 10.1111/epi.13348. Epub 2016 Mar 6. Epilepsia. 2016. PMID: 26945677
-
MicroRNAs and target genes in epileptogenesis.Epilepsia. 2020 Oct;61(10):2086-2096. doi: 10.1111/epi.16687. Epub 2020 Sep 18. Epilepsia. 2020. PMID: 32944964 Review.
-
Genome-wide circulating microRNA expression profiling indicates biomarkers for epilepsy.Sci Rep. 2015 Mar 31;5:9522. doi: 10.1038/srep09522. Sci Rep. 2015. PMID: 25825351 Free PMC article.
-
Epilepsy and microRNA.Neuroscience. 2013 May 15;238:218-29. doi: 10.1016/j.neuroscience.2013.02.027. Epub 2013 Feb 26. Neuroscience. 2013. PMID: 23485811 Review.
Cited by
-
LncRNA ILF3-AS1 mediates oxidative stress and inflammation through miR-504-3p/HMGB1 axis in a cellular model of temporal lobe epilepsy.Brain Behav. 2024 Aug;14(8):e3615. doi: 10.1002/brb3.3615. Brain Behav. 2024. PMID: 39135276 Free PMC article.
-
Glycyrrhizic acid protects against temporal lobe epilepsy in young rats by regulating neuronal ferroptosis through the miR-194-5p/PTGS2 axis.Kaohsiung J Med Sci. 2023 Feb;39(2):154-165. doi: 10.1002/kjm2.12642. Epub 2023 Jan 17. Kaohsiung J Med Sci. 2023. PMID: 36647717 Free PMC article.
-
Potential Role of miRNAs as Theranostic Biomarkers of Epilepsy.Mol Ther Nucleic Acids. 2018 Dec 7;13:275-290. doi: 10.1016/j.omtn.2018.09.008. Epub 2018 Sep 13. Mol Ther Nucleic Acids. 2018. PMID: 30321815 Free PMC article. Review.
-
Inhibition of microRNA-34a Suppresses Epileptiform Discharges Through Regulating Notch Signaling and Apoptosis in Cultured Hippocampal Neurons.Neurochem Res. 2019 May;44(5):1252-1261. doi: 10.1007/s11064-019-02772-x. Epub 2019 Mar 15. Neurochem Res. 2019. PMID: 30877521
-
MicroRNAs as Immune Regulators of Inflammation in Children with Epilepsy.Int J Mol Cell Med. 2020 Summer;9(3):188-197. doi: 10.22088/IJMCM.BUMS.9.3.188. Epub 2020 Nov 10. Int J Mol Cell Med. 2020. PMID: 33274181 Free PMC article.
References
-
- Reschke C.R., Henshall D.C. microRNA and epilepsy. Adv. Exp. Med. Biol. 2015;888:41–70. [http://dx.doi.org/10.1007/978-3-319-22671-2_4]. [PMID: 26663178]. - PubMed
-
- Shazadi K., Petrovski S., Roten A., Miller H., Huggins R.M., Brodie M.J., Pirmohamed M., Johnson M.R., Marson A.G., O’Brien T.J., Sills G.J. Validation of a multigenic model to predict seizure control in newly treated epilepsy. Epilepsy Res. 2014;108(10):1797–1805. [http://dx.doi.org/10.1016/j.eplepsyres.2014. 08.022]. [PMID: 25282706]. - PubMed
-
- Roncon P., Soukupovà M., Binaschi A., Falcicchia C., Zucchini S., Ferracin M., Langley S.R., Petretto E., Johnson M.R., Marucci G., Michelucci R., Rubboli G., Simonato M. MicroRNA profiles in hippocampal granule cells and plasma of rats with pilocarpine-induced epilepsy--comparison with human epileptic samples. Sci. Rep. 2015;5:14143. [http://dx.doi.org/10.1038/srep14143]. [PMID: 26382856]. - PMC - PubMed
-
- Li M.M., Li X.M., Zheng X.P., Yu J.T., Tan L. MicroRNAs dysregulation in epilepsy. Brain Res. 2014;1584:94–104. [http:// dx.doi.org/10.1016/j.brainres.2013.09.049]. [PMID: 24096213]. - PubMed
-
- Wang X., Sun Y., Tan Z., Che N., Ji A., Luo X., Sun X.
- Li X., Yang K., Wang G., Luan L., Liu Y., Wei M., Yin J. Serum MicroRNA-4521 is a potential biomarker for focal cortical dysplasia with refractory epilepsy. Neurochem. Res. 2016;41(4):905–912. [http://dx.doi.org/10.1007/s11064-015-1773-0]. [PMID: 26645999]. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical